C4 Therapeutics, Inc.
| Security | CCCC / C4 Therapeutics, Inc. |
| Insider | Kendra Adams |
This page shows the track record and history of Adams Kendra
insider trades in C4 Therapeutics, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.
It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean
it is illegal for them to make any
trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Kendra Adams in CCCC / C4 Therapeutics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Kendra Adams in CCCC / C4 Therapeutics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-19 | 2025-09-18 | 4 | Adams Kendra | CCCC | Common Stock | D | 3.3200 | -2,775 | -9 | 162,342 | ||||
| 2025-09-19 | 2025-09-18 | 4 | Adams Kendra | CCCC | Common Stock | D | 6,250 | 165,117 | ||||||
| 2025-02-18 | 2025-02-14 | 4 | Adams Kendra | CCCC | Common Stock | D | 3.1800 | -4,559 | -14 | 165,117 | ||||
| 2025-02-18 | 2025-02-14 | 4 | Adams Kendra | CCCC | Common Stock | D | 87,100 | 169,676 | ||||||
| 2025-02-18 | 2025-02-13 | 4 | Adams Kendra | CCCC | Common Stock | D | 3.2000 | -1,863 | -6 | 82,576 | ||||
| 2024-11-12 | 2024-11-07 | 4 | Adams Kendra | CCCC | Common Stock | D | 6.0400 | -1,102 | -7 | 84,439 | ||||
| 2024-11-12 | 2024-11-07 | 4 | Adams Kendra | CCCC | Common Stock | D | 3,750 | 85,541 | ||||||
| 2024-09-20 | 2024-09-18 | 4 | Adams Kendra | CCCC | Common Stock | D | 6.3800 | -1,837 | -12 | 81,791 | ||||
| 2024-09-17 | 2024-09-16 | 4 | Adams Kendra | CCCC | Common Stock | D | 6.3600 | -661 | -4 | 83,628 | ||||
| 2024-09-17 | 2024-09-16 | 4 | Adams Kendra | CCCC | Common Stock | D | 2,250 | 84,289 | ||||||
| 2024-02-15 | 2024-02-14 | 4 | Adams Kendra | CCCC | Common Stock | D | 36,700 | 82,039 | ||||||
| 2024-02-15 | 2024-02-13 | 4 | Adams Kendra | CCCC | Common Stock | D | 6.5300 | -1,301 | -8 | 45,339 | ||||
| 2023-09-19 | 3 | Adams Kendra | CCCC | Common Stock | D | 21,640 | ||||||||
| 2023-09-19 | 2023-09-18 | 4 | Adams Kendra | CCCC | Common Stock | D | 25,000 | 46,640 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
